Chloroquine and Hydroxychloroquine not licensed for COVID-19

Recent media reports have suggested that chloroquine can protect patients from coronavirus or treat COVID-19, the illness caused by a coronavirus.

The MHRA has reiterated that chloroquine and hydroxychloroquine are not licensed to treat COVID-19 related symptoms or prevent infection.

Clinical trials are ongoing to test chloroquine and hydroxychloroquine as an agent in the treatment of COVID-19 or to prevent COVID-19 infection. These clinical trials are still not completed, so no conclusions have been reached on the safety and effectiveness of this medicine to treat or prevent COVID-19.

The MHRA has said that until they have clear, definitive evidence these treatments are safe and effective for the treatment of COVID-19, they should only be used for this purpose within a clinical trial.

This story is being shared under the Open Government Copyright licence.